Ishida M, Masuda T, Sakai N, Nakai-Futatsugi Y, Kamao H, Shiina T
Commun Med (Lond). 2024; 4(1):187.
PMID: 39349587
PMC: 11442691.
DOI: 10.1038/s43856-024-00617-5.
Moyo M, Adali T, Tulay P
Regen Ther. 2024; 26:235-250.
PMID: 38966602
PMC: 11222715.
DOI: 10.1016/j.reth.2024.05.018.
Liu H, Lu S, Chen M, Gao N, Yang Y, Hu H
Stem Cell Rev Rep. 2024; 20(6):1459-1479.
PMID: 38809490
DOI: 10.1007/s12015-024-10740-4.
Perez V, Mousa H, Miyagishima K, Reed A, Su A, Greenwell T
Stem Cell Reports. 2024; 19(6):817-829.
PMID: 38729155
PMC: 11297553.
DOI: 10.1016/j.stemcr.2024.04.007.
Kajita K, Nishida M, Kurimoto Y, Yokota S, Sugita S, Semba T
Sci Rep. 2024; 14(1):10044.
PMID: 38698112
PMC: 11065889.
DOI: 10.1038/s41598-024-60895-w.
Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges.
Niu Y, Ji J, Yao K, Fu Q
Adv Ophthalmol Pract Res. 2024; 4(2):52-64.
PMID: 38586868
PMC: 10997875.
DOI: 10.1016/j.aopr.2024.02.001.
Recent Progress in Photoreceptor Cell-Based Therapy for Degenerative Retinal Disease.
Klymenko V, Gonzalez Martinez O, Zarbin M
Stem Cells Transl Med. 2024; 13(4):332-345.
PMID: 38417110
PMC: 11016853.
DOI: 10.1093/stcltm/szae005.
Eternal Youth: A Comprehensive Exploration of Gene, Cellular, and Pharmacological Anti-Aging Strategies.
Kitaeva K, Solovyeva V, Blatt N, Rizvanov A
Int J Mol Sci. 2024; 25(1).
PMID: 38203812
PMC: 10778954.
DOI: 10.3390/ijms25010643.
Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery.
Gupta S, Lytvynchuk L, Ardan T, Studenovska H, Sharma R, Faura G
Stem Cells Transl Med. 2023; 12(8):536-552.
PMID: 37459045
PMC: 10427969.
DOI: 10.1093/stcltm/szad039.
Soluble Collectin 11 (CL-11) Acts as an Immunosuppressive Molecule Potentially Used by Stem Cell-Derived Retinal Epithelial Cells to Modulate T Cell Response.
Fanelli G, Romano M, Lombardi G, Sacks S
Cells. 2023; 12(13).
PMID: 37443840
PMC: 10341155.
DOI: 10.3390/cells12131805.
Single-cell transcriptomics reveals maturation of transplanted stem cell-derived retinal pigment epithelial cells toward native state.
Parikh B, Blakeley P, Regha K, Liu Z, Yang B, Bhargava M
Proc Natl Acad Sci U S A. 2023; 120(26):e2214842120.
PMID: 37339216
PMC: 10293804.
DOI: 10.1073/pnas.2214842120.
Pluripotent stem cell-derived retinal organoid/cells for retinal regeneration therapies: A review.
Mandai M
Regen Ther. 2023; 22:59-67.
PMID: 36712956
PMC: 9841126.
DOI: 10.1016/j.reth.2022.12.005.
Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration.
Yang Y, Hsiao Y, Chang K, Foustine S, Ko Y, Tsai Y
Int J Mol Sci. 2022; 23(22).
PMID: 36430270
PMC: 9696562.
DOI: 10.3390/ijms232213794.
Competency of iPSC-derived retinas in MHC-mismatched transplantation in non-human primates.
Uyama H, Tu H, Sugita S, Yamasaki S, Kurimoto Y, Matsuyama T
Stem Cell Reports. 2022; 17(11):2392-2408.
PMID: 36306783
PMC: 9669501.
DOI: 10.1016/j.stemcr.2022.09.014.
The Prospects for Retinal Organoids in Treatment of Retinal Diseases.
Xue Y, Lin B, Chen J, Tang W, Browne A, Seiler M
Asia Pac J Ophthalmol (Phila). 2022; 11(4):314-327.
PMID: 36041146
PMC: 9966053.
DOI: 10.1097/APO.0000000000000538.
Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells.
Alvarez-Palomo B, Veiga A, Raya A, Codinach M, Torrents S, Ponce Verdugo L
Stem Cell Res Ther. 2022; 13(1):408.
PMID: 35962457
PMC: 9372949.
DOI: 10.1186/s13287-022-02961-6.
Long-term survival in non-human primates of stem cell-derived, MHC-unmatched corneal epithelial cell sheets.
Yoshinaga Y, Soma T, Azuma S, Maruyama K, Hashikawa Y, Katayama T
Stem Cell Reports. 2022; 17(7):1714-1729.
PMID: 35750044
PMC: 9287743.
DOI: 10.1016/j.stemcr.2022.05.018.
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy.
Nicholson M, Ting C, Chan D, Cheng Y, Lee Y, Hsu C
Cells. 2022; 11(11).
PMID: 35681550
PMC: 9180434.
DOI: 10.3390/cells11111853.
Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration.
Dehghan S, Mirshahi R, Shoae-Hassani A, Naseripour M
Stem Cell Res Ther. 2022; 13(1):217.
PMID: 35619143
PMC: 9137077.
DOI: 10.1186/s13287-022-02894-0.
Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy.
Morita Y, Kishino Y, Fukuda K, Tohyama S
Cell Prolif. 2022; 55(8):e13248.
PMID: 35534945
PMC: 9357358.
DOI: 10.1111/cpr.13248.